Juniper Square completes $130 million Series D
0
Juniper Square will use the capital to accelerate investment in JunieAI—the first enterprise-grade AI built specifically for the needs of private markets GPs. JunieAI combines the power of modern large language models (LLMs) with critical enabling components—Juniper Square's fund system of record for GPs and LPs, a scaled data model, comprehensive workflows coupled with managed services, industry integrations, and robust measures for security, control, and permissioning—to help GPs move faster, work smarter, and operate more efficiently.
Juniper Square announces $130 million Series D financing round and the launch of JunieAI
As an agentic AI platform, JunieAI provides:
Agents supporting the work of investor relations, fund administration, portfolio management, and investment decisions
Model-agnostic orchestration across agents, tools, workflows, and systems
Precision tools for the accuracy demands of accounting and reporting, fused with the ease of use and power of generative AI
Secure, enterprise-grade permissioning and control
Deep domain expertise in private markets
AI workflows wrapped with full service solutions
Unified structured and unstructured data—including from emails and documents
Seamless integration with existing GP tools
Fine-grained agent governance, empowering GPs to define how AI agents behave, respond, and defer across use cases
"The private markets are undergoing a once-in-a-generation transformation driven by two tsunamis of change: the rise of the retail investor and the breakthrough potential of AI," says Alex Robinson, CEO and Co-Founder at Juniper Square. "Our mission is to equip GPs with the technology and services they need to thrive in this new era. With JunieAI, we're helping our customers stay ahead—turning disruption into opportunity across every facet of work inside of the modern GP."
"Juniper Square is uniquely positioned to lead the private markets into the AI era," says Nick Shalek, General Partner at Ribbit Capital. "Few companies have the combination of enterprise-grade trust, enabling infrastructure, deep domain expertise, and structured data at scale that Juniper Square brings to bear. With JunieAI, they're harnessing these strengths to build AI solutions that are purpose-built for private markets—not just bolted on. We're thrilled to support Juniper Square as it sets the standard for how this industry will evolve."
This fundraise follows a period of rapid growth for Juniper Square including >100% 3-year CAGR in its fund administration business, which today manages over 2,000 fund entities globally across an extensive range of strategies and complex fund structures. Growth has been especially strong in the private equity and venture capital verticals, which now represent four of the five largest customers by revenue. In May, Juniper Square expanded into Luxembourg, unlocking integrated fund administration and efficient cross-border operations for private markets GPs at a global scale.
"Juniper Square stands out as a frontrunner to lead the private markets as the world moves toward an AI-driven future," says Jay Maher, Global Chief Operating Officer at H.I.G. Capital. "Juniper Square's focus on AI innovation will deliver transformative benefits across the industry—empowering organizations to better serve investors and drive long-term growth."
Over the past decade, Juniper Square has built the connected infrastructure that powers private markets, helping make the industry more efficient, transparent, and accessible. With retail investors reshaping the landscape and the market on track to exceed $60 trillion within a decade, GPs need innovations like JunieAI to keep pace and capture new opportunities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
19 minutes ago
- Times
Pope Leo urges young people to use AI for good
The Pope has urged a congregation of social media users to use artificial intelligence for human good rather than falling prey to its perils, striking a more upbeat tone than the fire-and-brimstone pronouncements in recent years favoured by his predecessor, Francis. The first American pope got a rave reception at the Mass in St Peter's Basilica on Tuesday, posing for selfies to roars from crowds, as hundreds held their phones above their heads to film it. Speaking in a mix of English, Spanish and Italian, he warned those gathered to reject the 'frivolity' of fake news and online encounters, urging young people not to 'count their followers' and instead 'work as agents of communion'. The Pope said: 'It is not simply a matter of generating content, but of creating an encounter between hearts. We have a duty to work together to develop a way of thinking, to develop a language, of our time, that gives voice to love.' Luis Antonio Tagle, the prominent Filipino cardinal who presided over the service, emphasised that everyone is an influencer in God's eyes. 'Daily life is a tapestry of crisscrossing influences,' he said. The rare encounter was part of a jubilee for young people that will culminate with a vigil and a Mass in a field on the outskirts of Rome. The biggest event of the Vatican's Holy Year, the weeklong celebration was expected to draw half a million young people in an influx likely to push the Eternal City's creaky public transport to its limits. Leo's words contrasted with those of Francis, who approved the publication of a 13,000-word document in January, three months before his death, claiming AI contained 'the shadow of evil' and could 'enslave' workers by limiting them to 'rigid and repetitive tasks'. • Cardinals attack Pope's liberal legacy in pre-conclave talks Even so, Leo's address also contained a warning: 'Nothing that comes from man and his creativity should be used to undermine the dignity of others,' he said. At the end of the Mass, the Pope called for an end to world conflicts, saying 'how much we need peace in these times torn apart by enmity and war'.
Telegraph
19 minutes ago
- Telegraph
AI researcher ‘turns down $1bn pay offer from Mark Zuckerberg'
A tech worker has reportedly turned down a $1bn (£750m) pay deal to join Mark Zuckerberg's artificial intelligence (AI) unit amid an escalating war for talent in Silicon Valley. Mr Zuckerberg's Meta reportedly offered several researchers who work at Thinking Machines, a San Francisco-based AI start-up, packages worth hundreds of millions of dollars to join the social media giant. One of those packages would have been worth as much as $1bn over several years, according to a report from Wired, while some researchers were also offered between $200m and $500m over a four-year period. Most deals included an award worth $50m to $100m in the first year. So far, no staff at the start-up have taken up an offer from Meta. Last month, Thinking Machines raised $2bn at a $12bn valuation, despite having no product. A spokesman for Meta disputed the claims, although confirmed it had made a 'handful' of offers to staff at Thinking Machines. 'We made offers only to a handful of people at Thinking Machines and while there was one sizeable offer, the details are off,' the spokesman said. Thinking Machines was founded by 36-year-old Mira Murati, a former OpenAI executive who has become one of the powerful women in tech since launching the company. AI arms race The eye-watering pay offers come amid an AI arms race, with tech giants trying to tempt leading AI scientists and programmers to join their efforts over those of rivals. Sam Altman, the chief executive of OpenAI which owns ChatGPT, previously claimed Meta had offered his staff deals worth as much as $100m. Mr Zuckerberg has been personally leading a recruitment drive to attract leading scientists and developers to a new lab within Meta in a race against rivals to build highly powerful AI tools. The Meta chief executive has reportedly been reaching out to dozens of targets with personalised WhatsApp messages and bumper pay deals. Meta is spending tens of billions of dollars on AI data centres that will be used to help create more powerful machine-learning tools that Mr Zuckerberg has claimed could soon transform the economy and society. He has also already recruited around 50 leading researchers and experts for a new 'superintelligence' lab within Meta, after growing frustrated at the lack of progress by his own engineers. Earlier this year, Meta delayed a major update to its AI technology, dubbed Behemoth. Mr Zuckerberg also engineered a $14.3bn deal to poach Alexandr Wang, the founder of AI business Scale AI, to lead his new team, acquiring a 49pc stake in the start-up in the process.
Reuters
19 minutes ago
- Reuters
US FDA's top vaccine official Vinay Prasad leaves agency after short stint
July 29 (Reuters) - The U.S. Food and Drug Administration's top official, Vinay Prasad, has left the agency after nearly three months as Director of the Center for Biologics Evaluation and Research, a government spokesperson said late on Tuesday. Prasad, an oncologist who previously criticized the FDA and was a fierce critic of U.S. COVID-19 vaccine and mask mandates, had been appointed in May. "Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family," a spokesperson from the Department of Health and Human Services told Reuters in an emailed statement. Endpoints News first reported Prasad's departure. His exit comes after a number of unusual regulatory actions, including those taken recently by the agency on Sarepta Therapeutics'(SRPT.O), opens new tab gene therapy, Elevidys. "Unprecedentedly, there were multiple press leaks from the FDA, negatively impacting (its) credibility," said BMO Capital Markets analyst, Koustas Billouri. During Prasad's short stint, the U.S. FDA limited the use of COVID-19 vaccines and declined to approve therapies from Replimmune (REPL.O), opens new tab and Capricor Therapeutics (CAPR.O), opens new tab. The regulator's decisions under Prasad raised concerns that he was anti-patient choice, Jefferies analyst Roger Song said, adding that investors will see his departure as a positive for gene therapy and vaccine makers. The Nasdaq Biotechnology Index (.NBI), opens new tab declined 7% on Prasad's appointment, but has since recovered. Shares of Replimmune rose 58%, Sarepta was up 11.2% and Capricor added 21.2% in premarket trading on Wednesday. Prasad also held the additional role of the agency's chief medical and science officer, to which he was appointed last month, according to STAT News. Nominating a more seasoned official to replace him could help the FDA rebuild its credibility, BMO's Billouri said.
